Company Search:
Advanced Search
Sponsored Links
IDL Biotech AB Company Snapshot
IDL Biotech AB operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares IDL Biotech AB with three other pharmaceutical manufacturers in Europe: RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS of Turkey (2016 sales of 31.81 million Turkish Liras [US$8.37 million] ), Hemcheck Sweden AB (28,425.00 Swedish Kronor [US$3,547.44 ] ), and Epigenomics AG which is based in Germany (4.20 million Euro [US$5.15 million] of which 53% was Product sales (own and third party)).

Sales Analysis. IDL Biotech AB reported sales of SEK 33.49 million (US$4.18 million) for the year ending December of 2016. This represents an increase of 17.5% versus 2015, when the company's sales were SEK 28.52 million. Sales at IDL Biotech AB have increased during each of the previous five years (and since 2011, sales have increased a total of 130%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
IDL Biotech AB
  Stock Performance Chart for IDL Biotech AB
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 2.80
(Figures in Swedish Kronor)
1 Week -3.4%   13 Weeks 14.8%  
4 Weeks -2.1%   52 Weeks -12.5%  
IDL Biotech AB Key Data:
  Ticker: IDL B Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 33,494,191
(Year Ending Jan 2017).
Employees: 12
  Currency: Swedish Kronor Market Cap: 76,546,929
  Fiscal Yr Ends: December Shares Outstanding: 27,338,189
  Share Type: B Aktie Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.